United States
Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
South Africa
United Kingdom
On Target
Similar topics: radiation and cancers
Chart positions today · Philippines
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like OncLive® On Air, try…
Breast Cancer Insights
Similar topics: cancer and breast
Gynecologic Oncology Update
Similar topics: cancers and gynecologic
Gastrointestinal Cancer Update
Similar topics: cancers and oncology
Oncology Brothers: Practice-Changing Cancer Discussions
Similar topics: oncology and cancers
SGO on the GO
Similar topics: oncology and gynecologic
Ranking history · Philippines
No ranking history for this show in Philippines over the last 7 days.
Latest episodes
-
Weigh Benefit Against Burden: Defining Lurbinectedin’s Role in a Shifting Small Cell Lung Cancer Landscape
October 19, 2026 · 22 minIn today’s episode, we spoke with Triparna Sen, PhD, and Jacob Sands, MD. Dr Sen is a professor of internal medicine and the director of the Lung Cancer Preclinical Therapeutics Platform at the Ohio State University Comprehensive Cancer…
-
FDA Approval Insights: First-Line Maintenance Tucatinib/Trastuzumab/Pertuzumab in Advanced HER2+ Breast Cancer
October 16, 2026 · 11 minIn today’s episode, we spoke with Erika P. Hamilton, MD, about the FDA approval of tucatinib (Tukysa) plus trastuzumab (Herceptin) and pertuzumab (Perjeta) for the maintenance treatment of adult patients with unresectable locally advanced…
-
Biology-Driven Care and AI Tools Steer the Future of Breast Oncology
October 15, 2026 · 27 minIn this episode of Oncology Unplugged, host Chandler Park, MD, MSc, FACP, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, was joined by Jame Abraham, MD, FACP, the enterprise chairman of the Department of…
-
Subcutaneous, On-Body Administration Opens Potential Door for At-Home Treatment in Multiple Myeloma
October 14, 2026 · 11 minIn this episode, produced in coordination with Oncology Nursing News®, Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, and Sikander Ailawadhi, MD, discussed how on-body subcutaneous administration methods could allow for select at-home…
-
Sequencing B7-H4–Targeted ADCs and Optimizing Toxicity Management in Gynecologic Cancers
October 14, 2026 · 16 minIn today’s episode, we spoke with Angeles Alvarez Secord, MD, MHSc. Dr Secord is a professor of obstetrics and gynecology and a member of Duke Cancer Institute in Durham, North Carolina. In our exclusive interview, Dr Secord discussed the…
Show 7 more episodesShow fewer episodes
-
The Next Wave: ADCs, Targeted Therapies, and Emerging Strategies in Ovarian Cancer
October 14, 2026 · 34 minFrom Discovery to Delivery: Charting Progress in Gynecologic Oncology, hosted by Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Dr…
-
Navigating Patient-Centric Treatment Administration Strategies in Myeloma
October 9, 2026 · 9 minIn this episode, produced in coordination with Oncology Nursing News®, Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, and Sikander Ailawadhi, MD, discussed how on-body subcutaneous administration methods are affecting multiple myeloma…
-
Novel MEK inhibitor Research Aims to Balance Efficacy and Tolerability in Pancreatic Cancer
October 7, 2026 · 11 minIn today’s episode, we spoke with Vincent Chung, MD, about the development of atebimetinib (IMM-1-104) in metastatic pancreatic cancer. Dr Chung is a professor in the Department of Medical Oncology & Therapeutics Research at City of Hope…
-
FDA Approval Insights: Ropeginterferon Alfa-2b Ushers in Long-Awaited New Treatment Option for Essential Thrombocythemia
October 2, 2026 · 13 minIn today’s episode, we welcomed Ruben Mesa, MD, FACP, who outlined the significance of the August 2026 FDA approval of ropeginterferon alfa-2b-njft (Besremi) for the treatment of adult patients with essential thrombocythemia. Dr Mesa is…
-
FDA Approval Insights: Daraxonrasib for Metastatic Pancreatic Ductal Adenocarcinoma
September 30, 2026 · 12 minIn today’s episode, we spoke with Kim A. Reiss Binder, MD, about the August 2026 FDA approval of daraxonrasib (Rasonque) for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least 1 prior…
-
Resistance Patterns Shape FGFR Inhibitor Sequencing in Cholangiocarcinoma
September 30, 2026 · 16 minIn this episode, we spoke with Arndt Vogel, MD, a faculty member at the University of Toronto Institute of Medical Science, a scientist at the Toronto General Hospital Research Institute, and a medical oncologist at the UHN–Princess…
-
Subcutaneous Therapies Bolster Administration Options in Multiple Myeloma
September 30, 2026 · 14 minIn this episode, produced in coordination with Oncology Nursing News®, Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, and Sikander Ailawadhi, MD, discussed evolving administration strategies for multiple myeloma therapies, primarily…
About the show
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.